Safety and Efficacy of PDpoetin for Management of Anemia in Patients with end Stage Renal Disease on Maintenance Hemodialysis: Results from a Phase IV Clinical Trial

Recombinant human erythropoietin (rHuEPO) is available for correcting anemia. PDpoetin, a new brand of rHuEPO, has been certified by Food and Drug Department of Ministry of Health and Medical Education of Iran for clinical use in patients with chronic kidney disease. We conducted this post-marketing...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Javidan, Abbas Norouzi, Shahbazian, Heshmatollah, Emami, Amirhossein, Yekaninejad, Mir Saeed, Emami-Razavi, Hassan, Farhadkhani, Masoumeh, Ahmadzadeh, Ahmad, Gorjipour, Fazel
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: PAGEPress Publications, Pavia, Italy 2014
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4194381/
https://ncbi.nlm.nih.gov/pubmed/25317316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2014.5195
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak